IP Library Granted Patent US 8,708,496
Granted Patent B2
US 8,708,496 · App. 13/207,171 · Granted Apr 29, 2014

Methods for imaging ocular devices using optical coherence tomography

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,708,496
App. No.
13/207,171
Granted
Apr 29, 2014
Kind
B2
Abstract

Described herein are methods for imaging ocular devices. The methods generally involve (a) applying a scattering agent to the ocular device; and (b) imaging the ocular device using optical coherence tomography (OCT). The methods described herein provide useful structural information about the surface of the device with high sensitivity.

Claims (17)

1. A method for imaging an ocular device comprising:

a. applying a scattering agent to the ocular device, wherein the scattering agent comprises a pigment;

b. rinsing the device;

c. submerging the device in a solution of water, saline, or a buffered solution; and

d. imaging the ocular device using optical coherence tomography (OCT).

2. The method of claim 1 , wherein the pigment comprises Green Cr 2 O 3 , Yellow Iron Oxide, or any combination thereof.

3. The method of claim 2 , wherein the ocular device is a contact lens.

4. The method of claim 2 , wherein the ocular device is an intraocular lens.

5. The method of claim 1 , wherein the pigment comprises a water-insoluble salt that forms in situ on the surface of the device, throughout the device, or a combination thereof.

6. The method of claim 5 , wherein the water-insoluble salt comprises a silver salt.

7. The method of claim 3 , wherein the ocular device is a contact lens.

8. The method of claim 1 , wherein step (a) comprises submerging the ocular device in a solution comprising the scattering agent.

9. The method of claim 8 , wherein the ocular device is imaged in a solution of the scattering agent.

10. The method of claim 1 , wherein the ocular device is imaged in a solution of the scattering agent.

11. The method of claim 1 , wherein the device is imaged by a Frequency Domain OCT, Fourier-domain OCT (FDOCT), complex Fourier OCT, Optical Frequency-domain imaging, or swept-source OCT.

12. The method of claim 1 , wherein the ocular device is a contact lens.

13. The method of claim 1 , wherein the ocular device is an intraocular lens.

Assignments (2)
CONFIRMATORY DEED OF ASSIGNMENT EFFECTIVE APRIL 8, 2019 Recorded Dec 10, 2019
From: NOVARTIS AG
To: ALCON INC.
Reel/Frame 051454/0788 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 14, 2012
From: GU, YEMING; BOWDEN, REBECA KYKER; HALL, WILLIAM JORDAN; MULCAHY, DEBORAH J.; QIU, YONGXING; SULLIVAN, BENJAMIN DAVID; TUCKER, ROBERT CAREY
To: NOVARTIS AG
Reel/Frame 027859/0041 →